CAMBRIDGE, Mass. — Cambridge BioMarketing (CB), a full-service healthcare marketing communications agency focused on orphan and specialty pharmaceuticals, names industry veteran Maureen Franco as Partner, Chief Strategy Officer.
In this new position, Ms Franco will “unify our Account Management, Clinical Sciences, and Digital Services departments into a best-in-class strategic group focused in orphan and specialty markets. And her global commercialization experience from industry adds a broader relevance and deeper resonance to the capabilities we bring to our clients,” according to CB CEO and Chief Creative Officer, Steve West.
Prior to joining CB, Ms. Franco spent 12 years at Genzyme in Cambridge where she held a number of executive leadership roles in commercial development, product marketing, global brand management, and product promotions. The last position she held was VP Global Marketing in their rare genetic disease division. Ms. Franco is a graduate of Boston College. She began her career in healthcare public relations and pharmaceutical advertising in Boston and Chicago.
“Many of our clients are developing first-ever therapies for rare or specialized conditions where the disease requires as much definition as the drug. We’re lucky to have someone of Maureen’s caliber to lead the strategic collaboration it takes to solve those unique brand challenges, “ added Mr. West.
